![]() |
|||||||
|
Select Publications
Lynch TJ et al. Preliminary treatment patterns and safety outcomes for non-small cell lung cancer (NSCLC) from ARIES, a bevacizumab treatment observational cohort study (OCS). Proc ASCO 2008;Abstract 8077.
Manegold C et al. Randomised, double-blind multicentre phase III study of bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-naïve patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): BO17704. Proc ASCO 2007;Abstract LBA7514.
Pirker R et al. FLEX: A randomized, multicenter, phase III study of cetuximab in combination with cisplatin/vinorelbine (CV) versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC). Proc ASCO 2008;Abstract 3.
Sandler A et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355(24):2542-50. Abstract
Table of Contents | Top of Page |
EDITOR
Neil Love, MD
INTERVIEWS
Thomas J Lynch, MD
- Select publications
F Anthony Greco, MD
- Select publications
Robert Pirker, MD
- Select publications
Lung Cancer Update:
A CME Audio Series and Activity
![]() |
![]() |
![]() |
![]() |
![]() |